Announced
Completed
Synopsis
Microba Life Sciences, an Australian publicly listed company engaged in the discovery and development of therapeutics for major chronic diseases and delivers gut microbiome testing service, completed the acquisition of Invivo Clinical, a UK microbiome wellness testing space, for £11m. The acquisition will help Microba establish a leading position in microbiome testing, with an established customer and geographical base in the UK and deep access to the UK healthcare market spanning both private practice and the public NHS environment.
Show Details & Financials
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.